XAGE

Profile

Full Name

Longevity Health Holdings, Inc.

Ticker Symbol

XAGE

Exchange

NASDAQ

Sector

Consumer Defensive

Industry

Household & Personal Products

Country

United States

IPO

September 23, 2021

Indexes

Not included

Website

http://www.carmellcosmetics.com

Employees

15

Key Details

Price

$0.20(+63.20%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$50.30K

Annual EPS

-$0.49(+66.44% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.20
XAGE price is $0.20

30-Day Relative Volume

24.06
XAGE 30-day relative volume is 24.06

Price Performance

Price Most recent change

+63.2%
XAGE price was up +63.2% on Apr 14, 2025

Price YTD change

-26.88%
XAGE price is down -26.88% since January 1st

Price 1-year change

-91.54%
XAGE price is down -91.54% year-on-year

Price 3-year change

-97.91%
XAGE price is down -97.91% over the past 3 years

Price Range

Price All-time high

$13.31
XAGE price is currently -98.47% below its historical high of $13.31

Price 3-year low

$0.10
XAGE price is currently +104.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$6.14M
XAGE market capitalization is $6.14 million

Market cap 3-year change

-
XAGE market capitalization 3-year change is unknown

Market cap All-time high

$187.36M
XAGE market capitalization is currently -96.72% below its historical high of $187.36 million

Market cap sector rank

11.6%
XAGE market capitalization is higher than 11.6% of companies in Consumer Defensive sector

Shares Outstanding

Shares Outstanding 1-Year Change

+55.57%
XAGE shares outstanding is up +55.57% year-on-year

Shares Outstanding 3-Year Change

-
XAGE shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.60
XAGE beta is 0.60

200-day SMA

$0.51
XAGE price is currently -59.95% below its 200-day simple moving average

50-day SMA

$0.21
XAGE price is currently -5.12% below its 50-day simple moving average

RSI

57.76
XAGE 14-day relative strength index is 57.76

Volume

24.06
XAGE 30-day relative volume is 24.06

ATR

$0.05
XAGE average true range is $0.05

10-day Historical Volatility

327.71%
XAGE 10-day historical volatility is 327.71%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$50.30K
XAGE annual revenue is $50.30 thousand

Revenue Analysts estimate

-
XAGE annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
XAGE annual revenue 1-year change is unknown

Revenue Sector rank

-
XAGE annual revenue is unknown

EPS

EPS

-$0.49
XAGE annual earnings per share is -$0.49

EPS Analysts estimate

-
XAGE annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+66.44%
XAGE annual earnings per share is up +66.44% year-on-year

EPS Sector rank

-
XAGE annual earnings per share is unknown

Profit

Gross profit

$44.00K
XAGE annual gross profit is $44.00 thousand

Gross margin

87.37%
XAGE annual gross profit margin is 87.37%

Operating profit

-$5.00M
XAGE annual operating income is -$5.00 million

Operating margin

-9933.82%
XAGE annual operating profit margin is -9933.82%

Net income

-$10.37M
XAGE annual net profit is -$10.37 million

Net margin

-20.61K%
XAGE annual net profit margin is -20.61 thousand%

Expenses

Total expenses

$5.05M
XAGE annual total expenses is $5.05 million

Operating expenses

$5.04M
XAGE annual total operating expenses is $5.04 million

Cost of goods sold

$6400.00
XAGE annual cost of goods sold is $6400.00

Selling, general & administrative expenses

$3.90M
XAGE annual SGA is $3.90 million

Depreciation and amortization

$197.30K
XAGE annual depreciation & amortization is $197.30 thousand

Interest expense

$49.00K
XAGE annual interest expense is $49.00 thousand

Income tax

-$97.30K
XAGE annual income tax is -$97.30 thousand

EBIT & EBITDA

EBIT

-$10.70M
XAGE annual earnings before interest & taxes is -$10.70 million

EBITDA

-$10.50M
XAGE annual EBITDA is -$10.50 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.47M
XAGE annual total assets is $1.47 million

Non current assets

$518.40K
XAGE annual long term assets is $518.40 thousand

Current assets

$955.60K
XAGE annual total current assets is $955.60 thousand

Cash and cash equivalents

$157.10K
XAGE annual cash & cash equivalents is $157.10 thousand

Accounts receivable

$4100.00
XAGE annual accounts receivable is $4100.00

Inventory

$108.70K
XAGE annual inventory is $108.70 thousand

Liabilities

Total liabilities

$6.19M
XAGE annual total liabilities is $6.19 million

Long term liabilities

$309.90K
XAGE annual total long term liabilities is $309.90 thousand

Current liabilities

$5.88M
XAGE annual total current liabilities is $5.88 million

Accounts payable

$4.06M
XAGE annual accounts payable is $4.06 million

Debt

Total debt

$639.00K
XAGE annual total debt is $639.00 thousand

Total debt 1-year change

-70.09%
XAGE annual total debt is down -70.09% year-on-year

Long term debt

$309.90K
XAGE annual long term debt is $309.90 thousand

Short term debt

$329.10K
XAGE annual short term debt is $329.10 thousand

Equity & Capital

Shareholders equity

-$4.71M
XAGE annual stockholders equity is -$4.71 million

Book value

-$4.71M
XAGE annual book value is -$4.71 million

Retained earnings

-$68.87M
XAGE annual retained earnings is -$68.87 million

Working capital

-$4.92M
XAGE annual working capital is -$4.92 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$4.39M
XAGE annual cash flow from operations is -$4.39 million

Cash from operations 1-year change

+47.43%
XAGE annual cash flow from operations is up +47.43% year-on-year

Cash from investing

-$748.80K
XAGE annual cash flow from investing activities is -$748.80 thousand

Cash from investing 1-year change

-2355.08%
XAGE annual cash flow from investing activities is down -2355.08% year-on-year

Cash from financing

$2.38M
XAGE annual cash flow from financing activities is $2.38 million

Cash from financing 1-year change

-78.66%
XAGE annual cash flow from financing activities is down -78.66% year-on-year

CAPEX

CAPEX

-
XAGE annual capital expenditures value is unknown

CAPEX 1-year change

-
XAGE annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$4.39M
XAGE annual free cash flow is -$4.39 million

Free cash flow 1-year change

+47.62%
XAGE annual free cash flow is up +47.62% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

87.37%
XAGE annual gross profit margin is 87.37%

Operating margin

-9933.82%
XAGE annual operating profit margin is -9933.82%

Net margin

-20.61K%
XAGE annual net profit margin is -20.61 thousand%

ROA & ROE

ROA

-703.41%
XAGE annual return on assets is -703.41%

ROE

-103.49%
XAGE annual return on equity is -103.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
XAGE price to earnings ratio value is unknown

PE ratio Sector rank

-
XAGE price to earnings ratio is unknown

PB Ratio

PB ratio

-1.30
XAGE price to book ratio is -1.30

PB ratio Sector rank

4.86%
XAGE price to book ratio is higher than 4.86% of companies in Consumer Defensive sector

PS Ratio

PS ratio

122.16
XAGE price to sales ratio is 122.16

PS ratio Sector rank

100.46%
XAGE price to sales ratio is higher than 100.46% of companies in Consumer Defensive sector

Enterprise value

Enterprise value

$6.63M
XAGE enterprise value is $6.63 million

Enterprise value Sector rank

7.72%
XAGE enterprise value is higher than 7.72% of companies in Consumer Defensive sector

EV/EBITDA

EV/EBITDA

-0.63
XAGE EV/EBITDA is -0.63

EV/EBITDA Sector rank

23.04%
XAGE EV/EBITDA is higher than 23.04% of companies in Consumer Defensive sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.16
XAGE annual current ratio is 0.16

Quick ratio

0.14
XAGE annual quick ratio is 0.14

Leverage

Debt to equity

-0.05
XAGE annual debt to equity ratio is -0.05

Interest coverage ratio

-218.34
XAGE annual interest coverage ratio is -218.34

Risk & Stability

Piotroski F-Score

-
XAGE piotroski f-score value is unknown

Altman Z-Score

-92.74
XAGE altman z-score is -92.74

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

WAFU logo
Wah Fu Education Group Limited (WAFU)
GSUN logo
Golden Sun Education Group Limited (GSUN)
Innovation Beverage Group Limited (IBG)
KAVL logo
Kaival Brands Innovations (KAVL)
CLEU logo
China Liberal Education Holdings Limited (CLEU)
CIMG (IMG)
DDC Enterprise Limited (DDC)
EAST logo
Eastside Distilling (EAST)
Healthy Choice Wellness (HCWC)
  • What is the ticker symbol for Longevity Health Holdings?
  • Does Longevity Health Holdings pay dividends?
  • What sector is Longevity Health Holdings in?
  • What industry is Longevity Health Holdings in?
  • What country is Longevity Health Holdings based in?
  • When did Longevity Health Holdings go public?
  • Is Longevity Health Holdings in the S&P 500?
  • Is Longevity Health Holdings in the NASDAQ 100?
  • Is Longevity Health Holdings in the Dow Jones?
  • When was Longevity Health Holdings's last earnings report?
  • When does Longevity Health Holdings report earnings?

What is the ticker symbol for Longevity Health Holdings?

The ticker symbol for Longevity Health Holdings is NASDAQ:XAGE

Does Longevity Health Holdings pay dividends?

No, Longevity Health Holdings does not pay dividends

What sector is Longevity Health Holdings in?

Longevity Health Holdings is in the Consumer Defensive sector

What industry is Longevity Health Holdings in?

Longevity Health Holdings is in the Household & Personal Products industry

What country is Longevity Health Holdings based in?

Longevity Health Holdings is headquartered in United States

When did Longevity Health Holdings go public?

Longevity Health Holdings's initial public offering (IPO) was on September 23, 2021

Is Longevity Health Holdings in the S&P 500?

No, Longevity Health Holdings is not included in the S&P 500 index

Is Longevity Health Holdings in the NASDAQ 100?

No, Longevity Health Holdings is not included in the NASDAQ 100 index

Is Longevity Health Holdings in the Dow Jones?

No, Longevity Health Holdings is not included in the Dow Jones index

When was Longevity Health Holdings's last earnings report?

Longevity Health Holdings's most recent earnings report was on Nov 14, 2024

When does Longevity Health Holdings report earnings?

The next expected earnings date for Longevity Health Holdings is May 15, 2025
On this page